Bionics

Zealand Pharma Announces Full Year Results for 2022

Retrieved on: 
Thursday, March 2, 2023
DREAM, Boehringer Ingelheim, CHI, Congenital hyperinsulinism, Safety, SAD, Congress, Insulin, FDA, European Medicines Agency, Novo Nordisk, Short bowel syndrome, MAA, NDA, Human, Patient, BMI, MAD, Marketing, GIP, PIN, S&M, Webcast, G&A, Dasiglucagon, Obesity, Glucagon, Q&A, EASE, EMA, SBS, Bionics, Cryptocurrency, Pharmaceutical industry, Alexion, DKK

Boehringer Ingelheim is planning to share the results of the trial with the scientific community in the coming months.

Key Points: 
  • Boehringer Ingelheim is planning to share the results of the trial with the scientific community in the coming months.
  • Separately, in the second half of 2023, Zealand expects to initiate a 13-week dose titration trial in people with obesity.
  • In the second half of the year, Zealand expects to report topline results from the ongoing 6-week multiple ascending dose (MAD) trial (NCT05613387) and initiate a 16-week dose titration trial.
  • Zealand anticipates advancing ZP6590 into a Phase 1 SAD trial in healthy volunteers in the second half of 2023.

Ekso Bionics to Showcase Integrated Functional Electrical Stimulation for Indego Therapy at APTA Meeting

Retrieved on: 
Thursday, February 23, 2023
Functional electrical stimulation, FES, American Physical Therapy Association, Facial muscles, Bionics, Patient, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, SAN, Ekso Bionics, Stroke, Food, Rehabilitation, Medical device

SAN RAFAEL, Calif., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced it will showcase the new Ekso Indego Therapy with Functional Electrical Stimulation (FES) at the upcoming American Physical Therapy Association’s Combined Sections Meeting on February 23-25 in San Diego, California.

Key Points: 
  • SAN RAFAEL, Calif., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced it will showcase the new Ekso Indego Therapy with Functional Electrical Stimulation (FES) at the upcoming American Physical Therapy Association’s Combined Sections Meeting on February 23-25 in San Diego, California.
  • The Company recently filed a Premarket Notification 510(k) with the U.S. Food and Drug Administration that covers the addition of integrated FES hardware and software to Ekso Indego Therapy, a lower-limb powered exoskeleton recently acquired by Ekso.
  • “This unique integrated solution is a testament to Ekso Bionics’ continued commitment to innovation and delivering on our promise of maximizing patient outcomes,” said Scott Davis, Chief Executive Officer of Ekso Bionics.
  • Ekso Indego Therapy with FES will automatically adapt timing of stimulation to match a patient’s speed in motion+ and advanced gait programs, and each of the ten FES channels may be customized, allowing for individualized user settings and therapy programs.

Outlook on the Bionic Devices Global Market to 2027: Cochlear Implant Device Will Lead in Treatment Type - ResearchAndMarkets.com

Retrieved on: 
Tuesday, February 21, 2023
Medical Devices, Health, Hearing, Nerve, Medtronic, Hearing loss, Longevity, Diaphragm, Abbott, Hospital, Research, FDA, Implant failure, Investment, Growth, WHO, Paraplegia, Conditional sentence, Electronics, Assistive technology, Movement, Dental implant, Prevalence, Kool-Aid, Medical device, Health insurance, Exoskeleton, Bionics

According to our research findings, Worldwide Bionic Devices Market size was US$ 5.41 Billion in 2022.

Key Points: 
  • According to our research findings, Worldwide Bionic Devices Market size was US$ 5.41 Billion in 2022.
  • Based on treatment type, the global bionic devices market is divided into; Cochlear Implants, Exoskeletons, Bionic Cardiology, and Ventricular Assist Devices.
  • Based on technology, the global bionic devices market is categorized into; electronics and mechanical devices.
  • North America has the highest market due to the high prevalence of chronic diseases, rising healthcare expenditure, and acceptance of bionic devices.

Entitle Launches With $15M in Seed Funding to Bake Security Into Permissions Management

Retrieved on: 
Wednesday, February 22, 2023
Cloud, Software as a service, DevOps, Automation, Israel Defense Forces, Deep learning, Security, Principle of least privilege, CISO, Pain, Access, SOX, Research, Bionics, Google Drive, Accelerated Access Review, IDF, Risk management, Lemonade, Partner (business rank), Cryptocurrency, Security (finance), Entitlement theory

NEW YORK, Feb. 22, 2023 /PRNewswire/ -- Entitle today announced that it has exited stealth with $15 million in seed financing and launched its cloud permissions management platform. The round was led by Glilot Capital Partners with participation by angel investors including more than 10 CISO's from Unicorn companies. Founded in 2021 by two former members of an elite team within the Israel Defense Force's renowned Unit 8200, Entitle applies their expertise in deep learning, security operations and vulnerability research to deliver a cloud permissions management platform that fuses a security-first approach with a commitment to business enablement.

Key Points: 
  • With the rapid adoption of cloud-based apps and infrastructure , IT and DevOps teams find themselves responsible for hundreds of thousands of permissions.
  • Entitle eliminates provisioning-related bottlenecks so security leaders can painlessly enforce the Principle of Least Privilege while maintaining a seamless user experience.
  • "Our expertise in the IDF was in operational security and the core problems underlying permissions management are operational.
  • "The Entitle platform takes the risk management burden off DevOps teams and onto security, where it belongs.

Asia Pacific Artificial Organs and Bionics Markets, Competition, Forecast & Opportunities, 2028 - ResearchAndMarkets.com

Retrieved on: 
Friday, January 27, 2023
Cardiology, Biotechnology, Managed Care, Other Health, Diabetes, Health, General Health, Health Technology, Medical Devices, Hospitals, Surgery, Forecast, Disability, Accident, Artificiality, Bionics, Pelvic floor dysfunction, Organic, Country, 3D bioprinting, Competition, Artificial organ, Artificial intelligence, Kidney, Amputation, Growth, Conditional sentence, Environment, Video game, Retail, Agriculture, Tissue paper, Others

Asia Pacific artificial organs and bionics market is expected to grow at a significant rate during the forecast period, 2024-2028.

Key Points: 
  • Asia Pacific artificial organs and bionics market is expected to grow at a significant rate during the forecast period, 2024-2028.
  • To analyze and forecast the market size of Asia Pacific artificial organs and bionics market.
  • To classify and forecast Asia Pacific artificial organs and bionics market based on product, technology, material, end-user, company and country.
  • Company Profiles: Detailed analysis of the major companies present in Asia Pacific artificial organs and bionics market.

Vicarious Surgical Announces Changes to Board of Directors

Retrieved on: 
Monday, January 23, 2023
Surgery, Medical Devices, Health, Robotics, Technology, Bionics, Monmouth College, Minerva Surgical, Inc. v. Hologic, Inc., Dental implant, University of Illinois at Chicago, Acquisition, Patient, University, Iowa State University, Boston Scientific, Immunology, Medical device, Sonova, Microbiology, Biology, Science

Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced the appointment of Victoria Carr-Brendel, Ph.D. to the Vicarious Surgical Board of Directors effective today, January 23, 2023.

Key Points: 
  • Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced the appointment of Victoria Carr-Brendel, Ph.D. to the Vicarious Surgical Board of Directors effective today, January 23, 2023.
  • The Company also announced the resignation of technology-focused venture capitalist Phil Liang from the Vicarious Surgical Board of Directors effective as of today.
  • “On behalf of the board, I’d like to thank Phil for his critical guidance and expertise as Vicarious Surgical navigated the pathway from tech start-up to publicly traded surgical robotics company,” said David Styka, Chairman of the Vicarious Surgical Board.
  • “We are thrilled to welcome Victoria to the Vicarious Surgical team.

Vial Announces the Addition of Dr. Rajat N Agrawal to their Ophthalmology CRO Scientific Advisory Board

Retrieved on: 
Wednesday, February 15, 2023
Keck School of Medicine of USC, University of Southern California, SAB, Patient, Hospital, Entrepreneurship, Artificial intelligence, Bionics, Retina, University, Senior, Optometry, SAN, Glaucoma, Rezolution Pictures, USC, Ophthalmology, Vial

SAN FRANCISCO, Feb. 14, 2023 /PRNewswire/ -- Vial , a global CRO providing next-generation clinical trial management services, announced the addition of Dr. Rajat N Agrawal to Vial's scientific advisory board (SAB).

Key Points: 
  • SAN FRANCISCO, Feb. 14, 2023 /PRNewswire/ -- Vial , a global CRO providing next-generation clinical trial management services, announced the addition of Dr. Rajat N Agrawal to Vial's scientific advisory board (SAB).
  • Dr. Agrawal, an ophthalmologist and retina specialist, will work closely with the company's leadership team to enhance the scientific strategy of Vial's Ophthalmology CRO products and services.
  • "We are thrilled to welcome Dr. Agrawal to our SAB, bringing his extensive experience in clinical development, artificial intelligence, and Ophthalmology to Vial," said Simon Burns, CEO and Co-Founder of Vial.
  • "I am excited to join Vial and contribute to their mission of providing technology-driven clinical trial management services in Ophthalmology," said Dr. Agrawal.

MicroCloud Hologram (NASDAQ: HOLO) Develops 3D-BIM Blockchain NFT Technology

Retrieved on: 
Thursday, February 2, 2023
Blockchain, SDT, InterPlanetary File System, IPFS, Research, Bionics, Drawing, Data management, NFT, 3D, Cryptocurrency

BEIJING, Feb. 2, 2023 /PRNewswire/ -- MicroCloud Hologram Inc. (NASDAQ: HOLO) ("HOLO" or the "Company"), a Hologram Digital Twins Technology provider, today announced its development of a 3D-BIM multi-user collaborative design solution based on blockchain NFT technology.

Key Points: 
  • BEIJING, Feb. 2, 2023 /PRNewswire/ -- MicroCloud Hologram Inc. (NASDAQ: HOLO) ("HOLO" or the "Company"), a Hologram Digital Twins Technology provider, today announced its development of a 3D-BIM multi-user collaborative design solution based on blockchain NFT technology.
  • HOLO applies blockchain NFT technology to achieve highly reliable and traceable data management through the distributed ledger and consensus mechanism.
  • HOLO has built a repository of holographic digital twins based on blockchain NFT technology, which holographic developers and designers rely on.
  • HOLO provides customized holographic digital technology integration services based on blockchain NFT technology for corporate clients with tailored business needs.

Bionic Integrates with Wiz to Unify Cloud Application Security

Retrieved on: 
Wednesday, January 11, 2023
Cloud, Software, OS, API, Organization, PII, Blog, ASPM, PCI, Risk, PALO, PHI, Wiz, Google Cloud Platform, Risk management, Online shopping, Bionics

PALO ALTO, Calif., Jan. 11, 2023 /PRNewswire/ -- Bionic, the industry's first Application Security Posture Management (ASPM) platform, today announced a product integration with cloud security leader Wiz to provide customers with an agentless way to unify and scale their cloud and application security posture in production. With this integration, DevSecOps teams now have complete visibility and context into which cloud security vulnerabilities impact business applications and sensitive data flows so they can prioritize and resolve threats faster, before their cloud infrastructure, applications, and business are impacted.

Key Points: 
  • Integration combines Bionic's next-gen application security with Wiz's next-gen cloud security to enable every company to secure their cloud infrastructure, applications, and workloads at scale
    PALO ALTO, Calif., Jan. 11, 2023 /PRNewswire/ -- Bionic , the industry's first Application Security Posture Management (ASPM) platform, today announced a product integration with cloud security leader Wiz to provide customers with an agentless way to unify and scale their cloud and application security posture in production.
  • To solve this, Bionic partnered with Wiz to unify cloud and application security posture at scale in production.
  • "With this integration, we are proud to combine Bionic's best-in-breed application security with Wiz's best-in-breed cloud security to provide customers with full cyber-risk coverage.
  • Together, Wiz and Bionic provide customers with an agentless way to unify and scale their cloud and application security posture in production.

University of Electro-Communications Research and Innovation: Precipitation on the radar

Retrieved on: 
Wednesday, January 11, 2023
Communication, PAWR, Stress (mechanics), IIT-BHU, Bionics, Electronics, Muramatsu, Research, Skin, Electrode, University of Electro-Communications, Tissue, UEC, Indian Institutes of Technology, University, Saitama University, Food industry, Instrumentation, Medical device, Element

"The human body is composed of many biological tissues, such as skin, muscle, fat, bone, and different types of organs," explains Muramatsu.

Key Points: 
  • "The human body is composed of many biological tissues, such as skin, muscle, fat, bone, and different types of organs," explains Muramatsu.
  • "These tissues and organs are electrically unique materials that interact with electromagnetic waves in a complex manner.
  • Specifically, they assessed the instrument's accuracy of precipitation measurements by comparing with data obtained from a disdrometer (a device used for measuring raindrop sizes and velocities).
  • http://www.ru.uec.ac.jp/randi/news/
    On October 4 2022, the University of Electro-Communications (UEC) signed a general agreement with Indian Institute of Technology, Varanasi (IIT-BHU) to promote further international collaboration.